Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
656 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03878407 | Identification of Patients With Age-Related Clonal Hematopoiesis (ARCH) Among Cancer Survivors(ARCH-001) | active not recruiting | — | 2,400 | University Health Network, TorontoOTHER | 1 | Feb 3, 2025 | clinicaltrials |
| NCT03740503 | Genomic Investigation of Unusual Responders(GENIUS) | recruiting | — | 100 | University Health Network, TorontoOTHER |
| 1 |
| Jan 31, 2025 |
| clinicaltrials |
| NCT04151368 | Surgical and Patient Reported Outcomes of Robotic Nipple-Sparing Mastectomy(RNSM) | suspended | N/A | 30 | University Health Network, TorontoOTHER | 1 | Jan 31, 2025 | clinicaltrials |
| NCT04962672 | Anesthesia Induced Brain Cancer Survival (ABC Survival): A Feasibility Study | recruiting | N/A | 40 | University Health Network, TorontoOTHER | 1 | Jan 31, 2025 | clinicaltrials |
| NCT05388149 | Kadcyla And Neratinib for Interception of HER2+ Breast Cancer With Molecular Residual Disease | recruiting | Phase 2 | 15 | University Health Network, TorontoOTHER | 1 | Jan 31, 2025 | clinicaltrials |
| NCT06725121 | Using Radiotherapy and Immunotherapy to Treat Advanced Liver Cancer Before Transplant(MacroTrans) | recruiting | Phase 1 / Phase 2 | 48 | University Health Network, TorontoOTHER | 1 | Dec 16, 2024 | clinicaltrials |
| NCT02878473 | Liver Transplantation for Early Intrahepatic Cholangiocarcinoma(LT for iCCA) | terminated | Phase 2 | 2 | University Health Network, TorontoOTHER | 1 | Dec 13, 2024 | clinicaltrials |
| NCT03455608 | PRO-ACTIVE: Prophylactic Swallow Intervention for Patients Receiving Radiotherapy for Head and Neck Cancer(PRO-ACTIVE) | completed | N/A | 952 | University Health Network, TorontoOTHER | 2 | Dec 10, 2024 | clinicaltrials |
| NCT00956384 | One-stage Breast Reconstruction Using Dermal Matrix/Implant Versus Two-stage Expander/Implant Procedure(AllodermRCT) | completed | N/A | 198 | University Health Network, TorontoOTHER | 1 | Dec 5, 2024 | clinicaltrials |
| NCT02699229 | Non-linear Multimodal Microendoscopy for Lung Cancer Pathology | withdrawn | — | 0 | University Health Network, TorontoOTHER | 0 | Dec 4, 2024 | clinicaltrials |
| NCT06003179 | Optimizing Lymphodepletion to Improve Outcomes in Patients Receiving Cell Therapy With Kymriah(LOKI) | withdrawn | Phase 1 | 0 | University Health Network, TorontoOTHER | 1 | Nov 12, 2024 | clinicaltrials |
| NCT00843037 | Study Of Sunitinib In Patients With Recurrent Paraganglioma/Pheochromocytoma(SNIPP) | completed | Phase 2 | 25 | University Health Network, TorontoOTHER | 2 | Oct 17, 2024 | clinicaltrials |
| NCT06274892 | Remote Monitoring of Patient Reported Outcomes to Improve the Efficacy of the Acute Phase Radiotherapy Review Process(PROMOTE) | recruiting | N/A | 124 | University Health Network, TorontoOTHER | 1 | Oct 17, 2024 | clinicaltrials |
| NCT04005183 | Renal Cell Carcinoma Microenvironment Discovery Project(REMEDY) | completed | — | 146 | University Health Network, TorontoOTHER | 1 | Oct 10, 2024 | clinicaltrials |
| NCT04195503 | Liver Transplant for Stable, Advanced Intrahepatic Cholangiocarcinoma | enrolling by invitation | N/A | 10 | University Health Network, TorontoOTHER | 1 | Oct 10, 2024 | clinicaltrials |
| NCT05440864 | Durvalumab and Tremelimumab in Resectable HCC((NEOTOMA)) | recruiting | Phase 2 | 28 | University Health Network, TorontoOTHER | 3 | Oct 10, 2024 | clinicaltrials |
| NCT06587867 | Seronegative Myasthenia Gravis - Efgartigimod IV | unknown | Phase 3 | 30 | University Health Network, TorontoOTHER | 1 | Sep 19, 2024 | clinicaltrials |
| NCT04044040 | Symptom Screening With Targeted Early Palliative Care (STEP) for Patients With Advanced Cancer | completed | N/A | 116 | University Health Network, TorontoOTHER | 1 | Aug 28, 2024 | clinicaltrials |
| NCT02760238 | Myeloproliferative Neoplasms (MPNs) Patient Registry | recruiting | — | 5,000 | University Health Network, TorontoOTHER | 1 | Aug 27, 2024 | clinicaltrials |
| NCT06569225 | Gemcitabine/Cisplatin/Nab-Paclitaxel and Rilvegostomig in Resectable iCCA(NEOLANGIO) | not yet recruiting | Phase 2 | 40 | University Health Network, TorontoOTHER | 1 | Aug 26, 2024 | clinicaltrials |
| NCT03360994 | WATChmAN Virtual Testicular Cancer Clinic | active not recruiting | N/A | 144 | University Health Network, TorontoOTHER | 1 | Aug 21, 2024 | clinicaltrials |
| NCT03520218 | Evaluating Positron Emission Mammography Imaging of Suspicious Breast Abnormalities | completed | N/A | 25 | University Health Network, TorontoOTHER | 1 | Jul 17, 2024 | clinicaltrials |
| NCT02334761 | Biopsies in Oncology - Prospective Study of Impact on Patient's Quality of Life. | completed | — | 129 | University Health Network, TorontoOTHER | 1 | Jul 16, 2024 | clinicaltrials |
| NCT02864485 | Living Donor Liver Transplantation for Unresectable Colorectal Cancer Liver Metastases | recruiting | N/A | 20 | University Health Network, TorontoOTHER | 1 | Jun 18, 2024 | clinicaltrials |
| NCT05790226 | Sentry Study: Raman Spectroscopy on Ex Vivo Lungs | terminated | N/A | 9 | University Health Network, TorontoOTHER | 1 | May 8, 2024 | clinicaltrials |
| NCT01305915 | Getting Back on Track: An Educational Group for Women With Breast Cancer(GBOT) | completed | N/A | 444 | University Health Network, TorontoOTHER | 1 | Apr 15, 2024 | clinicaltrials |
| NCT02478138 | Sentinel Lymph Node Mapping of Oral Cancer Using Near-Infrared Fluorescence Imaging(SLN Mapping) | completed | N/A | 1 | University Health Network, TorontoOTHER | 1 | Apr 15, 2024 | clinicaltrials |
| NCT06362434 | Visual Telerehabilitation in Children, Adolescents and Young Adults With Hemianopsia Consecutive to a Brain Tumour(HHREHAB) | not yet recruiting | N/A | 50 | University Health Network, TorontoOTHER | 1 | Apr 12, 2024 | clinicaltrials |
| NCT01144468 | Effects of Exemestane on Bone Strength(MAP3BSS) | completed | — | 351 | University Health Network, TorontoOTHER | 2 | Mar 27, 2024 | clinicaltrials |
| NCT00889733 | Intraperitoneal (IP) Cisplatin Given With Paclitaxel to Treat Epithelial Ovarian Cancer(OVHM-01) | terminated | Phase 1 / Phase 2 | 9 | University Health Network, TorontoOTHER | 1 | Mar 26, 2024 | clinicaltrials |
| NCT06328491 | Erdafitinib in Metastatic Steroid-cell Ovarian Cancer | completed | N/A | 1 | University Health Network, TorontoOTHER | 1 | Mar 25, 2024 | clinicaltrials |
| NCT03345732 | Intraoperative Evaluation Using ICG and SPY Fluorescence to Prevent Wound Complications in Head and Neck Surgery. | withdrawn | — | 0 | University Health Network, TorontoOTHER | 1 | Mar 20, 2024 | clinicaltrials |
| NCT03380208 | Comparison of Endoscopic Visualization and CT Imaging of Head and Neck Cancers With Pathological Validation Study(EndoscopicHN) | completed | — | 3 | University Health Network, TorontoOTHER | 1 | Mar 20, 2024 | clinicaltrials |
| NCT03650699 | Biofeedback Rehabilitation to Improve Speaking and Eating in Public(Biofeedback) | completed | N/A | 34 | University Health Network, TorontoOTHER | 1 | Mar 20, 2024 | clinicaltrials |
| NCT03909893 | A Study of Adaptive Radiation Therapy for Pelvic Genitourinary Cancer(ARTGU) | withdrawn | N/A | 0 | University Health Network, TorontoOTHER | 1 | Mar 19, 2024 | clinicaltrials |
| NCT00188708 | Effect of Casodex on Tumour Hypoxia - Prostate Cancer | completed | N/A | 30 | University Health Network, TorontoOTHER | 1 | Mar 18, 2024 | clinicaltrials |
| NCT00789607 | Fiducial Localization and Individualized Radiotherapy -Prostate Cancer(FLIP) | completed | N/A | 17 | University Health Network, TorontoOTHER | 1 | Mar 18, 2024 | clinicaltrials |
| NCT02034955 | Prostatectomy Adaptive Radiation Therapy (ART) | completed | N/A | 21 | University Health Network, TorontoOTHER | 1 | Mar 18, 2024 | clinicaltrials |
| NCT01886066 | Accuracy of Sentinel Lymph Node Biopsy in Nodal Staging of High Risk Endometrial Cancer(EndoSLN) | completed | N/A | 156 | University Health Network, TorontoOTHER | 1 | Mar 15, 2024 | clinicaltrials |
| NCT02678884 | Head and Neck Squamous Cell Carcinoma (HNSCC)PET-CT Pilot Study | recruiting | N/A | 20 | University Health Network, TorontoOTHER | 1 | Mar 13, 2024 | clinicaltrials |
| NCT03320733 | Comparison Between Dual Energy/Subtraction CT With MRI for the Identification of Predictors of Malignancy in Cystic Pancreatic Lesions | completed | N/A | 46 | University Health Network, TorontoOTHER | 1 | Mar 12, 2024 | clinicaltrials |
| NCT02812680 | The Utility of Circulating Tumour Cells and Plasma microRNA in Esophageal Adenocarcinoma | completed | — | 84 | University Health Network, TorontoOTHER | 1 | Mar 8, 2024 | clinicaltrials |
| NCT03763396 | Azoles Targeting Recurrent High Grade Gliomas | not yet recruiting | Early Phase 1 | 30 | University Health Network, TorontoOTHER | 1 | Mar 8, 2024 | clinicaltrials |
| NCT01837225 | ALA-induced Fluorescence Imaging of Breast Cancers Using the Handheld PRODIGI and Eagle Imaging Devices | unknown | — | 90 | University Health Network, TorontoOTHER | 1 | Feb 13, 2024 | clinicaltrials |
| NCT06254781 | Luspatercept in Metastatic AGCT of the Ovary | completed | N/A | 1 | University Health Network, TorontoOTHER | 1 | Feb 12, 2024 | clinicaltrials |
| NCT05248425 | Study to Measure and Enhance the Health Related Quality Of Life in Cancer Patients(ME-Q) | withdrawn | N/A | 0 | University Health Network, TorontoOTHER | 1 | Feb 8, 2024 | clinicaltrials |
| NCT02543255 | Anti-Androgens and Cabazitaxel in Defining Complete Response in Prostatectomy (ACDC Trial)(ACDC-RP) | completed | Phase 2 | 76 | University Health Network, TorontoOTHER | 1 | Jan 31, 2024 | clinicaltrials |
| NCT01864096 | The Metformin Active Surveillance Trial (MAST) Study(MAST) | unknown | Phase 3 | 408 | University Health Network, TorontoOTHER | 1 | Jan 24, 2024 | clinicaltrials |
| NCT03432949 | Radium-223 Combined With Dexamethasone as First-line Therapy in Patients With M+CRPC(TRANCE) | unknown | Phase 4 | 24 | University Health Network, TorontoOTHER | 1 | Jan 24, 2024 | clinicaltrials |
| NCT04092179 | Study of Enasidenib and Venetoclax in IDH2-Mutated Blood Cancers | terminated | Phase 1 / Phase 2 | 27 | University Health Network, TorontoOTHER | 1 | Jan 24, 2024 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials